In India, the Russian-developed Corona Vaccine Sputnik V has been approved for emergency use. This is the third vaccine for the coronavirus to be approved after Kovshield (Serum Institute of India) and Kovaxin (Bharat Biotech).
The Sputnik V vaccine, developed by Moscow's Gamale National Research Institute of Epidemiology and Microbiology, uses two different viruses that cause the common cold (adenovirus) in humans. Adenovirus becomes weak so it cannot replicate in humans and cannot cause disease.
Let me tell you that this vaccine is also modified. For this reason, the vaccine provides a code for making the coronavirus spike protein. The purpose of this process is to ensure that when the actual virus tries to infect the body, it can mount an immune response in the form of antibodies.
Sputnik uses a different vector for each of the two shots during vaccination. According to this Russian Direct Investment Fund (RDIF), the same methods are used for both shots. It provides immunity with a longer duration than other vaccines. A difference of 21 days is required for both shots.
Sputnik V (liquid) is stored at a temperature of minus 18 ° C. However, its dried form can be stored at 2–8 ° C. This does not require investing in cold-chain infrastructure. According to the RDIF, Sputnik V has been approved for the use of more than 150 crore people in 55 countries. The vaccine is proposed to be priced below $ 10 per shot. Although its price in India has not been decided.
Dr. Reddy's labs based in Hyderabad sought government approval for the vaccine in India. RDIF partnered with Dr. Reddy's in September 2020 to conduct clinical trials in the country. On Monday, the Subject Expert Committee (SEC) of the Drugs Controller General of India took the Sputnik V application for Emergency Use Authority and moved on. DCGI previously sought additional data from the drug manufacturer.
Five other Indian companies have partnered with RDIF for Sputnik V. These include Gland Pharma, Hetero Biopharma, Virchow Biotech, Panacea Biotech, and Stellis Biopharma, Bangalore-based Strides Pharma Science's bioceramic. It is expected from their partnerships that India's capacity to manufacture this vaccine will exceed 60 million.
Amazon Deal On Smart Phone: If you are planning to buy a good phone for less than 10 thousand, th
The number of active cases of corona in the country has reached more than 7 thousand. 33 cases we
A new twist has come in the matter of urinating on a female passenger on an Air India flight. The
There is good news for the candidates who wish to devote themselves to the service of the country
Gujarat Titans suffered a defeat against Lucknow Super Giants on Thursday in IPL 2025. However, t
Once again, terrorism has started spreading its foot in the western-northern part of Pakistan. Ei
Trouble for former MD of Twitter India, SC sent a notice on UP government's petition
The Supreme Court has issued a notice in the FIR against Manish Maheshwari, former MD of Twitter
Next month, the world-famous Khatu Shyamji Phalguni fair will be held. More than 50 lakh devotees
Indian opener and Karnataka captain Mayank Agarwal was admitted to a local hospital on Tuesday af
The Supreme Court has given great relief to Nupur Sharma in the matter of their statement on Prop
